All Brands Owned by Bausch + Lomb Corporation

What does Bausch + Lomb own?
Bausch + Lomb owns a portfolio of approximately 400 eye health products across three segments. Vision Care includes contact lens brands (ULTRA, INFUSE, Biotrue One Day, SofLens) and lens care solutions (ReNu, Biotrue). Pharmaceuticals includes Lumify, Alrex, Lotemax, Zirgan, and Vyzulta. Surgical includes Crystalens, SofPort, and Akreos intraocular lenses and Stellaris surgical systems. The company has a presence in approximately 100 countries.

Is Bausch + Lomb publicly traded?
Yes. Bausch + Lomb Corporation trades on the New York Stock Exchange and the Toronto Stock Exchange under the ticker symbol BLCO. The company began trading on May 6, 2022, following an IPO that separated the eye health business from Bausch Health Companies. Bausch + Lomb files its own annual report (Form 10-K) with the SEC. Bausch Health retains approximately 88 percent of its shares.

Who founded Bausch + Lomb?
Bausch + Lomb was founded in 1853 in Rochester, New York, by John Jacob Bausch, an optician, and Henry Lomb, a financial backer. Both were German immigrants. Bausch opened a small optical goods store and borrowed $60 from Lomb to expand the business. The company is one of the oldest continually operating eye care companies in the world, with 173 years of history as of 2026.

What is Bausch + Lomb's revenue?
Bausch + Lomb reported 2025 total revenue of $5,101 million, up 6 percent from $4,791 million in 2024. The Vision Care segment contributed $2,923 million (57 percent), Pharmaceuticals contributed $1,284 million (25 percent), and Surgical contributed $894 million (approximately 18 percent). The company provided 2026 revenue guidance of $5.375 to $5.475 billion.

Where is Bausch + Lomb headquartered?
Bausch + Lomb is headquartered at 520 Applewood Crescent, Vaughan, Ontario, Canada, L4K 4B4. The company's historical and operational base remains in Rochester, New York, where it conducts significant contact lens manufacturing and research and development, employing more than 1,000 people.

What was the ReNu with MoistureLoc recall?
In 2006, Bausch + Lomb voluntarily withdrew ReNu with MoistureLoc lens care solution from the market after it was linked to an increased risk of Fusarium fungal keratitis, a serious eye infection. The company faced litigation and settled numerous claims. The product was discontinued. This event occurred before the company was acquired by Valeant (later Bausch Health) in 2013.

What is the ONE by ONE Recycling Program?
The ONE by ONE Recycling Program is a contact lens and eye care product recycling program operated in partnership with TerraCycle. It is described as the first and only such program in the United States. Participants bring used contact lenses, blister packs, lens cases, and eye drop containers to participating eye care practices. As of November 2025, the program had collected over 690,000 pounds of used eye health products.